Full Prescribing Information  |   Patient's Instructions for Use  |   Print Page  

IMPORTANT SAFETY INFORMATION
When switching from an oral corticosteroid medication to OMNARIS, patients may experience withdrawal symptoms such as joint or muscle pain, weakness, or depression.

OMNARIS may cause slowed growth in children.

Patients using doses of corticosteroid drugs that weaken the immune system are more susceptible to infection and should avoid exposure to chickenpox or measles.

Rare instances of wheezing, nasal irritation, and eye problems have been reported following the use of nasal sprays. Talk with your doctor if you have a history of eye problems or experience a change in vision.

The most common side effects that may occur with OMNARIS are headache, ear pain, sore throat, and nose bleed. Infections of the nose and throat are rare with OMNARIS use. If an infection occurs it may require treatment or discontinuation of OMNARIS.

For more information, please see the OMNARIS Full Prescribing Information and the OMNARIS Patient's Instructions for Use.

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. The products discussed herein may have different product labeling in different countries. All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient. OMNARIS is a medicine used to treat seasonal and year-round nasal allergies. Remember that no medicine is for everyone. Only your doctor can prescribe OMNARIS for you.

 

 

©2008 Sepracor Inc.  Marlborough, MA 01752  All rights reserved.
and Sepracor are registered trademarks of Sepracor Inc.
OMNARIS is a trademark of Nycomed GmbH, used with permission.